Ignite Creation Date:
2025-12-25 @ 4:54 AM
Ignite Modification Date:
2026-05-17 @ 3:27 PM
Study NCT ID:
NCT00168818
Status:
COMPLETED
Last Update Posted:
2014-05-19
First Post:
2005-09-12
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Dabigatran Etexilate in Extended Venous Thromboembolism (VTE) Prevention After Hip Replacement Surgery
Sponsor:
Boehringer Ingelheim
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
1160.48
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
Boehringer Ingelheim, Study Chair
Old Organization:
Boehringer Ingelheim